Barbara Rogers, CRNP, MN, AOCN, ANP- BC

Request Appointment
Clinical Locations
About
Education and Training
Patient Stories
Publications

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

Secondary Location

Fox Chase–Temple University Hospital Bone Marrow Transplant Program
Temple University Hospital – Jeanes Campus
Patient Care Center, Fifth Floor
7600 Central Avenue
Philadelphia, PA 19111

About

Assistant Professor, Academic Clinician

Specialties

Leukemia; Lymphoma; Myeloma

Treatment Philosophy

I choose to work at Fox Chase because of its reputation for providing compassionate high-quality nursing care. I have stayed at Fox Chase because of the atmosphere of continued professional growth and the emphasis on the caring component of health care.

Education and Training

Educational Background

Post-Masters Nurse Practitioner Certification Program, Temple University, Philadelphia, PA, 1995-1997
Masters of Nursing, Med-Surg Nursing, Oncology Specialization, University of California, Los Angeles, CA, 1982-1984
BS, Nursing, Trenton State College, Trenton, NJ, 1978

Certifications

Adult Nurse Practitioner-American Nurses Credentialing Center
Advanced Oncology Certified Nurse

Memberships

Society for Immunotherapy of Cancer (SITC)
Advanced Practitioner Society for Hematology and Oncology (APSHO)
Member, Education Committee APSHO
Putting Evidence Into Practice (PEP)-Pain Team, Oncology Nursing Society
Putting Evidence Into Practice (PEP)-Anorexia Team, Oncology Nursing Society
Lymphoma Research Foundation, T-cell Lymphoma Nurse Advisory Board
Leukemia/Lymphoma Society-Volunteer
Buxmont Nurse Practitioners
Nurse Practitioner Special Interest Group, Oncology Nursing Society
Philadelphia Area Chapter Oncology Nursing Society
Oncology Nursing Society

Honors & Awards

Daisy Award, Daisy Foundation, 2013
Philadelphia Chapter, Leukemia & Lymphoma Society Hematology/Oncology Nurse of the Year, Healthcare Professional Excellence Awards, 2006
Josh Gottheil Bone Marrow Transplant Professional Development Award, Oncology Nursing Society, 1998
Who's Who in American Nursing Award, 1996, 1994, 1992, 1990, 1988, 1986
Presidents's Award, Philadelphia Area Chapter, Oncology Nursing, 1991
International Who's Who of Professional & Business Women award, 1990
Sigma Theta Tau Honors Society of Nursing, 1986-Present
Nursing Award, San Fernando Valley Unit, American Cancer Society, 1985
Scholarship for Graduate Education, American Cancer Society, 1982-1984
Army Commendation Medal, 1981
Nomination for Evangeline G. Bovard Award, Letterman Army Medical Center, 1981

Patient Stories

Judith Bernstein

Breast Cancer; Lung Cancer; Lymphoma; Skin Cancer; Thyroid Cancer

Judith Bernstein

Breast Cancer; Lung Cancer; Lymphoma; Skin Cancer; Thyroid Cancer

As a person who has been diagnosed and treated for various types of cancer, I can say with certainty: Run, don’t walk, to Fox Chase Cancer Center. I have given this piece of advice more times than I can count because I know that where you begin your cancer treatment really does matter.

View Patient Story

Publications

Selected Publications

Rogers, B. & Khan, N. (2017). Supportive Care and Management of Treatment-Emergent Adverse Events in CLL. JADPRO, 8, 97-111.

Brant, J., Rogers, B., Gallagher, E., & Sundaramurthi, T. (2017). Breakthrough Cancer Pain. Clinical Journal of Oncology Nursing, 21, 71-80.

Gallagher, E., Rogers, B., & Brant, J. (2017). Cancer-related pain assessment. Clinical Journal of Oncology Nursing, 21, 8-12.

Brigle, K. & Rogers, B. (2017). Pathobiology and diagnosis of multiple myeloma. Seminars in Oncology Nursing, 33, 225-236.

Rogers, B. (2015). Effective Navigation of Patients with Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia. Best Practices in Patient Navigation. Part 4. Journal of Oncology Navigation & Survivorship (Suppl) 6, 9-10.

Rogers, B. (2015). Best Practices in Patient Navigation: Acute Promyelocytic Leukemia. Best Practices in Patient Navigation. Part 3. Journal of Oncology Navigation & Survivorship (Suppl) 6,9-10.

Rogers, B. (2015). The role of the oncology nurse navigator in improving supportive care. Best Practices in Patient Navigation. Part 2. Journal of Oncology Navigation & Survivorship (Suppl) 6, 11-12.

Rogers, B. (2015). The Nurse Navigator Role in the Management of Non-Hodgkin Lymphoma and Hodgkin Lymphoma. Best Practices in Patient Navigation. Part 1. Journal of Oncology Navigation & Survivorship (Suppl) 6, 11-12.

Rogers, B. (2014). Leukocytosis. In Camp-Sorrell & Hawkins (Eds.). Clinical Manual for the Oncology Advanced Practice Nurse (3rd Ed.). Pittsburgh; Oncology Nursing Society, pp 995-999.

Rogers, B. (2014). ImmuneThrombocytopenia. In Camp-Sorrell & Hawkins (Eds) Clinical Manual for the Oncology Advanced Practice Nurse (3rd Ed.). Pittsburgh; Oncology Nursing Society, pp 1019-1025.

Rogers, B. (2014). Polycythemia Vera. In Camp-Sorrell & Hawkins (Eds.). Clinical Manual for the Oncology Advanced Practice Nurse (3rd Ed.). Pittsburgh; Oncology Nursing Society, pp 1037-1043.

Rogers, B. (2014). Essential Thrombocythemia. In Camp-Sorrell & Hawkins (Eds.). Clinical Manual for the Oncology Advanced Practice Nurse (3rd Ed.). Pittsburgh; Oncology Nursing Society, pp 1067-1074.

Rogers, B. (2014). Monoclonal Gammopathy of Undetermined Significance. In Camp-Sorrell & Hawkins (Eds.). Clinical Manual for the Oncology Advanced Practice Nurse (3rd Ed.). Pittsburgh; Oncology Nursing Society,pp 1059-1065.

Rogers, B. (2014). Thrombocytopenia. In Camp-Sorrell & Hawkins (Eds.). Clinical Manual for the Oncology Advanced Practice Nurse (3rd Ed.). Pittsburgh; Oncology Nursing Society, pp 1075-1081.

Rogers, B. (2014). Neutropenia. In Camp-Sorrell & Hawkins (Eds.). Clinical Manual for the Oncology Advanced Practice Nurse (3rd Ed.). Pittsburgh; Oncology Nursing Society, 1027-1036... Expand

Rogers, B. (2013). Myelodysplastic/Myeloproliferative Diseases. In M. Olsen & L. Zitella (Eds.). Hematologic Malignancies. Pittsburgh: Oncology Nursing Society, pp 79-100.

Rogers, B. (2012). Improving patient outcomes in mantle cell lymphoma. Considerations in Lymphoma. Ask the Experts, 4,

Erb, C. & Rogers, B. (2012). Brentuximab vedotin for the treatment of relapsed/refractory HL and ALCL. The Oncology Nurse-APN/PA, 5, 13-16.

Rogers, B. (2010). Management of Lymphoma in the Elderly. Common Hematologic Malignancies in the Elderly-Removing Age as a Barrier to Effective Treatment. Meniscus Educational Institute.

Rogers, B. (2010). Current and emerging therapies for patients with relapsed/refractory peripheral T-cell Lymphoma. Nursing Strategies for Managing Patients with T-Cell Lymphoma. Oncologycases.com (released 12/1/10).

Rogers, B. (2010). Management of Lymphoma in the Elderly. Common Hematologic Malignancies in the Elderly-Removing Age as a Barrier to Effective Treatment. Meniscus Educational Institute.

Rogers, B. (2010). Advances in the Management of Acute Myeloid Leukemia in Older Adult Patients. Oncology Nursing Forum. 37(3) Online Exclusive.

Rogers, B. (2009) Chemotherapy-induced Nausea and Vomiting. The Oncology Nurse. 2(3), 18-22.

Rogers, B. (2007). AML Prognostic Indicators, Current Treatment Strategies, and Future Directions. New Strategies for the Treatment of Adult Acute Myeloid Leukemia. North Miami: Institute for Medical Education & Research, Inc., 1-2.

Rogers, B. (2006) Leukocytosis. In Camp-Sorrell & Hawkins (Eds.). Clinical Manual for the Oncology Advanced Practice Nurse (2nd Ed). Pittsburgh; Oncology Nursing Society, 819-822.

Lynch, M & Rogers, B. (2006) Idiopathic Thrombocytopenic Purpura. In D. Camp-Sorrell & R. Hawkins (Eds.). Clinical Manual for the Oncology Advanced Practice Nurse (2nd Ed.). Pittsburgh; Oncology Nursing Society, 819-822.

Lynch M & Rogers B. (2006). Neutropenia. In Camp-Sorrell & Hawkins (Eds.). Clinical Manual for the Oncology Advanced Practice Nurse. Pittsburgh; Oncology Nursing Society (2nd Ed.), 819-822.

Lynch M & Rogers B. (2006) Polycythemia Vera. In Camp-Sorrell & Hawkins (Eds) Clinical Manual for the Oncology Advanced Practice Nurse (2nd Ed.). Pittsburgh; Oncology Nursing Society, 819-822.

Lynch M & Rogers B. (2006). Thrombocytopenia. In Camp-Sorrell & Hawkins (Eds) second edition; Clinical Manual for the Oncology Advanced Practice Nurse. Pittsburgh; Oncology Nursing Society, 819-822.

Rogers, B. (2006). Overview of Non-Hodgkin’s Lymphoma. Seminars in Oncology Nursing, 22(2), 67-72.

Rogers, B. (2005) Looking at lymphoma and leukemia. Nursing 2005, July, 35(7), 56-63.

Rogers, B. (2002). Management of Anemia in the Ambulatory Patient with Cancer. Oncology Supportive Care, 1(1), 19-26.

Rogers, B. (2002). General Weight Loss in Cancer Patients : An Approach to Assessment and Care.
Medscape, http://www.medscape.com/viewarticle/440532_8.

Rogers, B. (2001). Mucositis in the Oncology Patient. Nursing Clinics of North America, 36(4), 745-760.

Schilder, R., Gallo, J., Millenson, M., Bookman, M., Weiner, L., Rogatko, A., Rogers, B., Padavic-Shallers, K., Boente, M., Rosenblum, N., Adams, A., Ciccotto, S., Ozols, R. (2001). Phase I Trial of Multiple Cycles of High-Dose Carboplatin, Paclitaxel, and Topotecan with Peripheral Blood Stem Cell Support as Front-Line Therapy. Journal of Clinical Oncology, 19: 1183-1194.

Springhouse Corp. (2000). Clinical Pharmacology Made Incredibly Easy (Reviewer). Springhouse,
Pennsylvania: Springhouse Corporation.

Schilder, R., Goldberg, M., Millenson M., Movsas, B., Rogatko, A., Rogers, B., & Langer, C. (2000).
Phase II trial of induction high dose chemotherapy followed by surgical resection and radiation therapy for
patients with marginally resectable non-small cell carcinoma of the lung. Lung Cancer, 27: 37-45.

Schilder, R., Johnson, S., Gallo, J., Kindsfather, S., Rogers, B., Bookman, M., Millenson, M., Boente,
M., Rosenblum, N., Litwin, S., & Ozols, R. (1999). Phase I Trial of Multiple Cycles of High-Dose
Chemotherapy Supported by Autologous Peripheral-Blood Stem Cells. Journal of Clinical Oncology, 17(7),
2198-2207.

Rogers, B. (1999). Preventing and Detecting Cancer Chemotherapy Drug Errors. Oncology Nursing
Updates; 6(1).

Springhouse. (1998). Pathophysiology Made Incredibly Easy. (Contributor). Springhouse, PA:
Springhouse Corporation.

Goldberg, M., Schilder, R., Rogers, B., Millenson, M., Dresler, C., Johnson, S., Gallo, J., Kilpatrick, D.,Yeung, C., Hiller, K., & Langer, C. (1998). Phase II trial of high-dose induction chemotherapy followed by surgical resection and radiation therapy in marginally resectable stage IIIA NSCLC. Cuneo Lung Cancer Study Group (Abstract); June 23, 1998.

Schilder, R., Gallo, J., Johnson, S., Kindsfather, S., Chernoff, M., Millenson, M., Bookman, M., Adams, A., Ciccotto, S., Boente, M., Rosenblum, N., Hogan, W., Rogers, B., Yeung, C., Kilpatrick, D.,
Hiller, K., Rogatko, A., Weiner, L., Ozols, R. (1998). Phase I study of multiple cycles of high dose topotecan, carboplatin, and paclitaxel with peripheral blood stem cell support. Proc Am Soc Clin Oncol 17:75a.

Schilder, R., Goldberg, M., Rogers, B., Millenson, M., Dresler, C., Johnson, S., Gallo, J., Kilpatrick, D.,
Yeung, C., Hiller, K., & Langer, C. (1997). Phase II trial of high-dose induction chemotherapy in
patients with stage IIIA non-small cell lung cancer. Proc Am Soc Clin Oncol, 16:481a.

Schilder, R., Rogers, B. & Kotz, K. (1995). "Improved Method for Infusing Cells" (Letter) Bone Marrow
Transplant 15:330.

Rogers, B. (1994). An Author Responds: Extravasation of Paclitaxel at Peripheral Sites (letter)
Oncology Nursing Forum; 21(6), 973.

Rogers, B. (1993). Taxol: A Promising New Drug of the 90's. Oncology Nursing Forum, 20(10)1483-
1489.

Rogers, B. (1993) Nursing Implications in the Administration of Palitaxel. Seminars in Oncology
Nursing, 9(4)11-15.

O'Dwyer, P., Hudes, G., Walczak, J., Schilder, R., LaCreta, F., Rogers, B., Cohen, I., Kowal, C., Whitfield, L., & Boyd., R. (1992). Phase I and Pharmacokinetic study of the Novel Platinum Anolog
CI-973 on a 5-Daily Dose Schedule. Cancer Research, 52:6746-6753.

McDermed, J. and Rogers, B. (1987) Handling of Injectable Antineoplastic Agents. Coping with Cancer
Chemotherapy: Understanding the Patients' Perspective. A.H. Robins Company. Collapse